株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

スマートピルの世界市場の分析:企業プロファイル、市場規模・シェア・成長率・傾向・将来予測

Global Smart pills Market, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

発行 Data Bridge Market Research Private Limited 商品コード 660585
出版日 ページ情報 英文 205 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.79円で換算しております。
Back to Top
スマートピルの世界市場の分析:企業プロファイル、市場規模・シェア・成長率・傾向・将来予測 Global Smart pills Market, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
出版日: 2018年06月01日 ページ情報: 英文 205 Pages
概要

当レポートでは、世界のスマートピル (スマート錠剤) 市場について分析し、市場の概況や市場シェア構造、主な市場促進・抑制要因、市場規模の動向見通し (今後8年間分)、用途別・疾患別・種類別・エンドユーザー別・地域別の詳細動向、市場競争環境、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 市場の内訳

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 課題

第6章 世界のスマートピル市場:用途別

  • 概要
  • カプセル内視鏡
    • 小腸用カプセル内視鏡
    • 大腸用カプセル内視鏡
  • ドラッグデリバリ (薬剤送達)
  • がん患者モニタリング

第7章 世界のスマートピル市場:疾患別

  • 概要
  • 潜在性消化管出血
  • クローン病
  • 小腸腫瘍
  • セリアック病
  • 遺伝性ポリポーシス症候群
  • 精神疾患

第8章 世界のスマートピル市場:種類別

  • 概要
  • 多重パラメーター・モニタリング
  • 単一パラメーター・モニタリング

第9章 世界のスマートピル市場:エンドユーザー別

  • 概要
  • 病院
  • 診断センター
  • その他

第10章 世界のスマートピル市場:地域別

  • 概要
  • 北米 (米国、カナダ、メキシコ)
  • 欧州 (ドイツ、フランス、英国、イタリア、スペイン、スイス、オランダ、ロシア、ベルギー、トルコなど)
  • アジア太平洋地域 (中国、日本、インド、韓国、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピンなど)
  • 南米 (ブラジルなど)
  • 中東・アフリカ (南アフリカなど)

第11章 世界のスマートピル市場:企業環境

  • 企業シェア分析:世界全体
  • 企業シェア分析:北米
  • 企業シェア分析:欧州
  • 企業シェア分析:アジア太平洋地域

第12章 企業プロファイル

  • MEDTRONIC
    • 企業概要
    • 市場収益額分析
    • 企業シェア分析
    • 製品ポートフォリオ
    • 近年の動向
  • 大塚ホールディングス
  • オリンパス
  • CAPSOVISION, INC.
  • CHECK CAP
  • INTROMEDIC
  • JINSHAN SCIENCE & TECHNOLOGY
  • LUCID GROUP LIMITED

第13章 関連分析

図表

LIST OF TABLES

  • TABLE 1 DIFFERENT CURRENT PROCEDURAL TERMINOLOGY (CPT) CODES FOR CAPSULE ENDOSCOPY PROCEDURES 39
  • TABLE 2 PRICES FOR THE CAPSULE ENDOSCOPY 41
  • TABLE 3 GLOBAL SMART PILLS MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 47
  • TABLE 4 GLOBAL CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 48
  • TABLE 5 GLOBAL CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY REGION, 2016-2025
  • (USD MILLION) 48
  • TABLE 6 GLOBAL DRUG DELIVERY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 49
  • TABLE 7 GLOBAL PATIENT MONITORING OF CANCER IN SMART PILLS MARKET, BY REGION,
  • 2016-2025 (USD MILLION) 50
  • TABLE 8 GLOBAL SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025, (USD MILLION) 53
  • TABLE 9 GLOBAL OCCULT GI BLEEDING IN SMART PILLS MARKET, BY REGION, 2016-2025
  • (USD MILLION) 53
  • TABLE 10 GLOBAL CROHN'S DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025
  • (USD MILLION) 54
  • TABLE 11 GLOBAL SMALL BOWEL TUMORS IN SMART PILLS MARKET, BY REGION, 2016-2025
  • (USD MILLION) 55
  • TABLE 12 GLOBAL CELIAC DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 56
  • TABLE 13 GLOBAL INHERITED POLYPOSIS SYNDROMES IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 57
  • TABLE 14 GLOBAL MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 58
  • TABLE 15 GLOBAL MENTAL DISORDERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 58
  • TABLE 16 GLOBAL SMART PILLS MARKET, BY TYPE, 2016-2025, (USD MILLION) 61
  • TABLE 17 GLOBAL MULTIPARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 62
  • TABLE 18 GLOBAL SINGLE PARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 63
  • TABLE 19 GLOBAL SMART PILLS MARKET, BY END USER, 2016-2025, (USD MILLION) 66
  • TABLE 20 GLOBAL HOSPITAL IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 66
  • TABLE 21 GLOBAL DIAGNOSTIC CENTERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 67
  • TABLE 22 GLOBAL OTHERS END USER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 68
  • TABLE 23 GLOBAL SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION) 73
  • TABLE 24 NORTH AMERICA SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 77
  • TABLE 25 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 77
  • TABLE 26 NORTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 78
  • TABLE 27 NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 78
  • TABLE 28 NORTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 79
  • TABLE 29 NORTH AMERICA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 79
  • TABLE 30 NORTH AMERICA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 80
  • TABLE 31 U.S. SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 81
  • TABLE 32 U.S. CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 81
  • TABLE 33 U.S. SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 82
  • TABLE 34 U.S. MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 82
  • TABLE 35 U.S. SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 83
  • TABLE 36 U.S. SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 83
  • TABLE 37 CANADA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 84
  • TABLE 38 CANADA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 84
  • TABLE 39 CANADA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 85
  • TABLE 40 CANADA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 85
  • TABLE 41 CANADA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 86
  • TABLE 42 CANADA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 86
  • TABLE 43 MEXICO SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 87
  • TABLE 44 MEXICO CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 87
  • TABLE 45 MEXICO SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 88
  • TABLE 46 MEXICO MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 88
  • TABLE 47 MEXICO SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 89
  • TABLE 48 MEXICO SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 89
  • TABLE 49 EUROPE SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 93
  • TABLE 50 EUROPE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 94
  • TABLE 51 EUROPE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 94
  • TABLE 52 EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 95
  • TABLE 53 EUROPE MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 95
  • TABLE 54 EUROPE SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 96
  • TABLE 55 EUROPE SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 96
  • TABLE 56 GERMANY SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 97
  • TABLE 57 GERMANY CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 97
  • TABLE 58 GERMANY SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 98
  • TABLE 59 GERMANY MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 98
  • TABLE 60 GERMANY SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 99
  • TABLE 61 GERMANY SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 99
  • TABLE 62 FRANCE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 100
  • TABLE 63 FRANCE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 100
  • TABLE 64 FRANCE SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 101
  • TABLE 65 FRANCE MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 101
  • TABLE 66 FRANCE SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 102
  • TABLE 67 FRANCE SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 102
  • TABLE 68 U.K. SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 103
  • TABLE 69 U.K. CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 103
  • TABLE 70 U.K. SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 104
  • TABLE 71 U.K. MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 104
  • TABLE 72 U.K. SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 105
  • TABLE 73 U.K. SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 105
  • TABLE 74 ITALY SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 106
  • TABLE 75 ITALY CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 106
  • TABLE 76 ITALY SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 107
  • TABLE 77 ITALY MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 107
  • TABLE 78 ITALY SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 108
  • TABLE 79 ITALY SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 108
  • TABLE 80 SPAIN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 109
  • TABLE 81 SPAIN CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 109
  • TABLE 82 SPAIN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 110
  • TABLE 83 SPAIN MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 110
  • TABLE 84 SPAIN SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 111
  • TABLE 85 SPAIN SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 111
  • TABLE 86 SWITZERLAND SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 112
  • TABLE 87 SWITZERLAND CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 112
  • TABLE 88 SWITZERLAND SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 113
  • TABLE 89 SWITZERLAND MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 113
  • TABLE 90 SWITZERLAND SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 114
  • TABLE 91 SWITZERLAND SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 114
  • TABLE 92 NETHERLANDS SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 115
  • TABLE 93 NETHERLANDS CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 115
  • TABLE 94 NETHERLANDS SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 116
  • TABLE 95 NETHERLANDS MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 116
  • TABLE 96 NETHERLANDS SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 117
  • TABLE 97 NETHERLANDS SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 117
  • TABLE 98 RUSSIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 118
  • TABLE 99 RUSSIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 118
  • TABLE 100 RUSSIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 119
  • TABLE 101 RUSSIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 119
  • TABLE 102 RUSSIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 120
  • TABLE 103 RUSSIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 120
  • TABLE 104 BELGIUM SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 121
  • TABLE 105 BELGIUM CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 121
  • TABLE 106 BELGIUM SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 122
  • TABLE 107 BELGIUM MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 122
  • TABLE 108 BELGIUM SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 123
  • TABLE 109 BELGIUM SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 123
  • TABLE 110 TURKEY SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 124
  • TABLE 111 TURKEY CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 124
  • TABLE 112 TURKEY SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 125
  • TABLE 113 TURKEY MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 125
  • TABLE 114 TURKEY SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 126
  • TABLE 115 TURKEY SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 126
  • TABLE 116 REST OF EUROPE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 127
  • TABLE 117 ASIA PACIFIC SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 131
  • TABLE 118 ASIA PACIFIC SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 132
  • TABLE 119 ASIA PACIFIC CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 132
  • TABLE 120 ASIA PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 133
  • TABLE 121 ASIA PACIFIC MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 133
  • TABLE 122 ASIA PACIFIC SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 133
  • TABLE 123 ASIA PACIFIC SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 134
  • TABLE 124 CHINA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 135
  • TABLE 125 CHINA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 135
  • TABLE 126 CHINA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 136
  • TABLE 127 CHINA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 136
  • TABLE 128 CHINA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 137
  • TABLE 129 CHINA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 137
  • TABLE 130 JAPAN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 138
  • TABLE 131 JAPAN CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 138
  • TABLE 132 JAPAN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 139
  • TABLE 133 JAPAN MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 139
  • TABLE 134 JAPAN SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 140
  • TABLE 135 JAPAN SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 140
  • TABLE 136 INDIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 141
  • TABLE 137 INDIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 141
  • TABLE 138 INDIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 142
  • TABLE 139 INDIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 142
  • TABLE 140 INDIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 143
  • TABLE 141 INDIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 143
  • TABLE 142 SOUTH KOREA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 144
  • TABLE 143 SOUTH KOREA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 144
  • TABLE 144 SOUTH KOREA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 145
  • TABLE 145 SOUTH KOREA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 145
  • TABLE 146 SOUTH KOREA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 146
  • TABLE 147 SOUTH KOREA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 146
  • TABLE 148 AUSTRALIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 147
  • TABLE 149 AUSTRALIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 147
  • TABLE 150 AUSTRALIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 148
  • TABLE 151 AUSTRALIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 148
  • TABLE 152 AUSTRALIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 149
  • TABLE 153 AUSTRALIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 149
  • TABLE 154 SINGAPORE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 150
  • TABLE 155 SINGAPORE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 150
  • TABLE 156 SINGAPORE SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 151
  • TABLE 157 SINGAPORE MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 151
  • TABLE 158 SINGAPORE SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 152
  • TABLE 159 SINGAPORE SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 152
  • TABLE 160 THAILAND SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 153
  • TABLE 161 THAILAND CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 153
  • TABLE 162 THAILAND SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 154
  • TABLE 163 THAILAND MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 154
  • TABLE 164 THAILAND SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 155
  • TABLE 165 THAILAND SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 155
  • TABLE 166 MALAYSIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 156
  • TABLE 167 MALAYSIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 156
  • TABLE 168 MALAYSIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 157
  • TABLE 169 MALAYSIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 157
  • TABLE 170 MALAYSIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 158
  • TABLE 171 MALAYSIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 158
  • TABLE 172 INDONESIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 159
  • TABLE 173 INDONESIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 159
  • TABLE 174 INDONESIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 160
  • TABLE 175 INDONESIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 160
  • TABLE 176 INDONESIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 161
  • TABLE 177 INDONESIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 161
  • TABLE 178 PHILIPPINES SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 162
  • TABLE 179 PHILIPPINES CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 162
  • TABLE 180 PHILIPPINES SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 163
  • TABLE 181 PHILIPPINES MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 163
  • TABLE 182 PHILIPPINES SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 164
  • TABLE 183 PHILIPPINES SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 164
  • TABLE 184 REST OF MIDDLE EAST & AFRICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 165
  • TABLE 185 SOUTH AMERICA SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 169
  • TABLE 186 SOUTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 169
  • TABLE 187 SOUTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 170
  • TABLE 188 SOUTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 170
  • TABLE 189 SOUTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 171
  • TABLE 190 SOUTH AMERICA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 171
  • TABLE 191 SOUTH AMERICA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 172
  • TABLE 192 BRAZIL SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 173
  • TABLE 193 BRAZIL CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 173
  • TABLE 194 BRAZIL SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 174
  • TABLE 195 BRAZIL MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 174
  • TABLE 196 BRAZIL SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 175
  • TABLE 197 BRAZIL SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 175
  • TABLE 198 REST OF SOUTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 176
  • TABLE 199 MIDDLE EAST AND AFRICA SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 180
  • TABLE 200 MIDDLE EAST AND AFRICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 180
  • TABLE 201 MIDDLE EAST AND AFRICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 181
  • TABLE 202 MIDDLE EAST AND AFRICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 181
  • TABLE 203 MIDDLE EAST AND AFRICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 182
  • TABLE 204 MIDDLE EAST AND AFRICA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 182
  • TABLE 205 MIDDLE EAST AND AFRICA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 183
  • TABLE 206 SOUTH AFRICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 184
  • TABLE 207 SOUTH AFRICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 184
  • TABLE 208 SOUTH AFRICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 185
  • TABLE 209 SOUTH AFRICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION) 185
  • TABLE 210 SOUTH AFRICA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION) 186
  • TABLE 211 SOUTH AFRICA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION) 186
  • TABLE 212 REST OF MIDDLE EAST & AFRICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 187

LIST OF FIGURES

  • FIGURE 1 GLOBAL SMART PILLS MARKET : SEGMENTATION 22
  • FIGURE 2 GLOBAL SMART PILLS MARKET : DATA TRIANGULATION 25
  • FIGURE 3 GLOBAL SMART PILLS MARKET : RESEARCH SNAPSHOT 26
  • FIGURE 4 GLOBAL SMART PILLS MARKET BOTTOM UP APPROACH 27
  • FIGURE 5 GLOBAL SMART PILLS MARKET TOP DOWN APPROACH 27
  • FIGURE 6 GLOBAL SMART PILLS MARKET : INTERVIEW DEMOGRAPHICS 28
  • FIGURE 7 GLOBAL SMART PILLS MARKET : SEGMENTATION 31
  • FIGURE 8 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL SMART PILLS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 32
  • FIGURE 9 INCREASING PREVALENCE OF GASTROINTESTINAL DISORDERS AND FAVORABLE REIMBURSEMENT POLICIES FOR CAPSULE ENDOSCOPY ARE EXPECTED TO DRIVE THE MARKET FOR GLOBAL SMART PILLS MARKET IN THE FORECAST PERIOD 2018 TO 2025 33
  • FIGURE 10 CAPSULE ENDOSCOPY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL SMART PILLS MARKET IN 2018 & 2025 33
  • FIGURE 11 ASIA PACIFIC IS THE MAXIMUM GROWING REGION FOR SMART PILLS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 34
  • FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL SMART PILLS MARKET 36
  • FIGURE 13 PERCENTAGE OF ADULT POPULATION DIAGNOSED WITH GASTROINTESTINAL CONDITIONS IN DIFFERENT COUNTRIES (2017) 37
  • FIGURE 14 GLOBAL SMART PILLS MARKET: BY APPLICATION, 2017 46
  • FIGURE 15 GLOBAL SMART PILLS MARKET: BY DISEASE INDICATION, 2017 52
  • FIGURE 16 GLOBAL SMART PILLS MARKET: BY TYPE, 2017 60
  • FIGURE 17 GLOBAL SMART PILLS MARKET: BY END USER, 2017 65
  • FIGURE 18 GLOBAL SMART PILLS MARKET SNAPSHOT (2017) 70
  • FIGURE 19 GLOBAL SMART PILLS MARKET: BY COUNTRY (2017) 71
  • FIGURE 20 GLOBAL SMART PILLS MARKET: BY COUNTRY (2018 & 2025) 71
  • FIGURE 21 GLOBAL SMART PILLS MARKET: BY COUNTRY (2017 & 2025) 72
  • FIGURE 22 GLOBAL SMART PILLS MARKET, BY APPLICATION (2018 - 2025) 72
  • FIGURE 23 NORTH AMERICA SMART PILLS MARKET SNAPSHOT (2017) 74
  • FIGURE 24 NORTH AMERICA SMART PILLS MARKET: BY COUNTRY (2017) 75
  • FIGURE 25 NORTH AMERICA SMART PILLS MARKET: BY COUNTRY (2018 & 2025) 75
  • FIGURE 26 NORTH AMERICA SMART PILLS MARKET: BY COUNTRY (2017 & 2025) 76
  • FIGURE 27 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION (2018 - 2025) 76
  • FIGURE 28 EUROPE SMART PILLS MARKET SNAPSHOT (2017) 90
  • FIGURE 29 EUROPE SMART PILLS MARKET: BY COUNTRY (2017) 91
  • FIGURE 30 EUROPE SMART PILLS MARKET: BY COUNTRY (2018 & 2025) 91
  • FIGURE 31 EUROPE SMART PILLS MARKET: BY COUNTRY (2017 & 2025) 92
  • FIGURE 32 EUROPE SMART PILLS MARKET, BY APPLICATION (2018 - 2025) 92
  • FIGURE 33 ASIA PACIFIC SMART PILLS MARKET SNAPSHOT (2017) 128
  • FIGURE 34 ASIA PACIFIC SMART PILLS MARKET: BY COUNTRY (2017) 129
  • FIGURE 35 ASIA PACIFIC SMART PILLS MARKET: BY COUNTRY (2018 & 2025) 129
  • FIGURE 36 ASIA PACIFIC SMART PILLS MARKET: BY COUNTRY (2017 & 2025) 130
  • FIGURE 37 ASIA PACIFIC SMART PILLS MARKET, BY APPLICATION (2018 - 2025) 130
  • FIGURE 38 SOUTH AMERICA SMART PILLS MARKET SNAPSHOT (2017) 166
  • FIGURE 39 SOUTH AMERICA SMART PILLS MARKET: BY COUNTRY (2017) 167
  • FIGURE 40 SOUTH AMERICA SMART PILLS MARKET: BY COUNTRY (2018 & 2025) 167
  • FIGURE 41 SOUTH AMERICA SMART PILLS MARKET: BY COUNTRY (2017 & 2025) 168
  • FIGURE 42 SOUTH AMERICA SMART PILLS MARKET, BY APPLICATION (2018 - 2025) 168
  • FIGURE 43 MIDDLE EAST AND AFRICA SMART PILLS MARKET SNAPSHOT (2017) 177
  • FIGURE 44 MIDDLE EAST AND AFRICA SMART PILLS MARKET: BY COUNTRY (2017) 178
  • FIGURE 45 MIDDLE EAST AND AFRICA SMART PILLS MARKET: BY COUNTRY (2018 & 2025) 178
  • FIGURE 46 MIDDLE EAST AND AFRICA SMART PILLS MARKET: BY COUNTRY (2017 & 2025) 179
  • FIGURE 47 MIDDLE EAST AND AFRICA SMART PILLS MARKET, BY APPLICATION (2018 - 2025) 179
  • FIGURE 48 GLOBAL SMART PILLS MARKET: COMPANY SHARE 2017 (%) 188
  • FIGURE 49 NORTH AMERICA SMART PILLS MARKET: COMPANY SHARE 2017 (%) 189
  • FIGURE 50 EUROPE SMART PILLS MARKET: COMPANY SHARE 2017 (%) 190
  • FIGURE 51 ASIA-PACIFIC SMART PILLS MARKET: COMPANY SHARE 2017 (%) 191
目次

Global smart pills market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as increasing prevalence of gastrointestinal disorders, rising cancer screening awareness programs and technological advancements and R&D investment in smart pills market.

The key market players for global smart pills market are listed below:

  • Medtronic
  • Otsuka Holdings Company Limited
  • Olympus Corporation
  • CapsoVision Inc.
  • Check-Cap
  • IntroMedic
  • JINSHAN Science & Technology
  • Lucid Group Limited

The market is further segmented into:

  • Application
  • Disease Indication
  • Type
  • End User

The global smart pills market is segmented on the basis of application into capsule endoscopy, drug delivery and patient monitoring of cancer. In 2018, capsule endoscopy segment is expected to dominate the smart pills market with 57.4% market share growing at the highest CAGR in the forecast period 2018 to 2025.

The global smart pills market is segmented on the basis of application into capsule endoscopy, drug delivery and patient monitoring of cancer. In 2018, capsule endoscopy segment is expected to dominate the market.

The global smart pills market is segmented on the basis of disease indication into occult GI bleeding, crohn's disease, small bowel tumors, celiac disease, inherited polyposis syndromes, mental disorders. In 2018, occult GI bleeding segment is expected to dominate the market.

The global smart pills market is segmented on the basis of type into multiparameter monitoring and single parameter monitoring. In 2018, multiparameter monitoring segment is expected to dominate the market in the forecast period.

The global smart pills market is segmented on the basis of end user into hospital, diagnostic centers and others. In 2018, hospital segment is expected to dominate the market

Based on geography, the market is segmented into 5 geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Covered in this report

The report covers the present scenario and the growth prospects of the global smart pills for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

1 INTRODUCTION 18

  • 1.1 OBJECTIVES OF THE STUDY 18
  • 1.2 MARKET DEFINITION 18
  • 1.3 OVERVIEW OF GLOBAL SMART PILLS MARKET 18
  • 1.4 CURRENCY AND PRICING 19
  • 1.5 LIMITATION 19
  • 1.6 MARKETS COVERED 20

2 MARKET SEGMENTATION 22

  • 2.1 MARKETS COVERED 22
  • 2.2 GEOGRAPHIC SCOPE 23
  • 2.3 YEARS CONSIDERED FOR THE STUDY 24
  • 2.4 CURRENCY AND PRICING 24
  • 2.5 RESEARCH METHODOLOGY 25
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
  • 2.7 SECONDARY SOURCES 29
  • 2.8 ASSUMPTIONS 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 33

5 MARKET OVERVIEW 35

  • 5.1 DRIVERS 37
    • 5.1.1 INCREASING PREVALENCE OF GASTROINTESTINAL DISORDERS 37
    • 5.1.2 RISING CANCER SCREENING AWARENESS PROGRAMS 38
    • 5.1.3 TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENT IN SMART PILLS MARKET 38
    • 5.1.4 FAVOURABLE REIMBURSEMENT POLICIES FOR CAPSULE ENDOSCOPY 39
    • 5.1.5 RISING NEED OF MINIMALLY INVASIVE SURGERIES 40
  • 5.2 RESTRAINTS 41
    • 5.2.1 HIGH COSTS OF SMART PILLS 41
    • 5.2.2 ETHICAL CONCERNS RELATED TO SMART PILLS FOR DRUG DELIVERY 41
  • 5.3 OPPORTUNITIES 42
    • 5.3.1 NEED FOR RAPID DRUG DEVELOPMENT PROCESS 42
    • 5.3.2 RISING NEED FOR THE FOCUS AND MOTIVATION IN DAILY LIFE FOR PEOPLE 42
  • 5.4 CHALLENGES 43
    • 5.4.1 LACK OF TRAINED STAFF 43
    • 5.4.2 POSSIBLE HEALTH RISK ASSOCIATED WITH A SMART PILL INSERTED INTO A BODY 44

6 GLOBAL SMART PILLS MARKET, BY APPLICATION 45

  • 6.1 OVERVIEW 46
  • 6.2 CAPSULE ENDOSCOPY 48
    • 6.2.1 SMALL BOWEL CAPSULE ENDOSCOPY 49
    • 6.2.2 COLON CAPSULE ENDOSCOPY 49
  • 6.3 DRUG DELIVERY 49
  • 6.4 PATIENT MONITORING OF CANCER 50

7 GLOBAL SMART PILLS MARKET, BY DISEASE INDICATION 51

  • 7.1 OVERVIEW 52
  • 7.2 OCCULT GI BLEEDING 53
  • 7.3 CROHN'S DISEASE 54
  • 7.4 SMALL BOWEL TUMORS 55
  • 7.5 CELIAC DISEASE 56
  • 7.6 INHERITED POLYPOSIS SYNDROMES 57
  • 7.7 MENTAL DISORDERS 58

8 GLOBAL SMART PILLS MARKET, BY TYPE 59

  • 8.1 OVERVIEW 60
  • 8.2 MULTIPARAMETER MONITORING 62
  • 8.3 SINGLE PARAMETER MONITORING 63

9 GLOBAL SMART PILLS MARKET, BY END USER 64

  • 9.1 OVERVIEW 65
  • 9.2 HOSPITAL 66
  • 9.3 DIAGNOSTIC CENTERS 67
  • 9.4 OTHERS 68

10 GLOBAL SMART PILLS MARKET, BY GEOGRAPHY 69

  • 10.1 GLOBAL 70
  • 10.2 NORTH AMERICA 74
    • 10.2.1 U.S. 81
    • 10.2.2 CANADA 84
    • 10.2.3 MEXICO 87
  • 10.3 EUROPE 90
    • 10.3.1 GERMANY 97
    • 10.3.2 FRANCE 100
    • 10.3.3 U.K. 103
    • 10.3.4 ITALY 106
    • 10.3.5 SPAIN 109
    • 10.3.6 SWITZERLAND 112
    • 10.3.7 NETHERLANDS 115
    • 10.3.8 RUSSIA 118
    • 10.3.9 BELGIUM 121
    • 10.3.10 TURKEY 124
    • 10.3.11 REST OF EUROPE 127
  • 10.4 ASIA PACIFIC 128
    • 10.4.1 CHINA 135
    • 10.4.2 JAPAN 138
    • 10.4.3 INDIA 141
    • 10.4.4 SOUTH KOREA 144
    • 10.4.5 AUSTRALIA 147
    • 10.4.6 SINGAPORE 150
    • 10.4.7 THAILAND 153
    • 10.4.8 MALAYSIA 156
    • 10.4.9 INDONESIA 159
    • 10.4.10 PHILIPPINES 162
    • 10.4.11 REST OF ASIA PACIFIC 165
  • 10.5 SOUTH AMERICA 166
    • 10.5.1 BRAZIL 173
    • 10.5.2 REST OF SOUTH AMERICA 176
  • 10.6 MIDDLE EAST AND AFRICA 177
    • 10.6.1 SOUTH AFRICA 184
    • 10.6.2 REST OF MIDDLE EAST & AFRICA 187

11 GLOBAL SMART PILLS MARKET, COMPANY LANDSCAPE 188

  • 11.1 COMPANY SHARE ANALYSIS: GLOBAL 188
  • 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 189
  • 11.3 COMPANY SHARE ANALYSIS: EUROPE 190
  • 11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 191

12 COMPANY PROFILE 192

  • 12.1 MEDTRONIC 192
    • 12.1.1 COMPANY OVERVIEW 192
    • 12.1.2 REVENUE ANALYSIS 192
    • 12.1.3 COMPANY SHARE ANALYSIS 193
    • 12.1.4 PRODUCT PORTFOLIO 193
    • 12.1.5 RECENT DEVELOPMENTS 193
  • 12.2 OTSUKA HOLDINGS COMPANY LIMITED 194
    • 12.2.1 COMPANY OVERVIEW 194
    • 12.2.2 REVENUE ANALYSIS 194
    • 12.2.3 COMPANY SHARE ANALYSIS 195
    • 12.2.4 PRODUCT PORTFOLIO 195
    • 12.2.5 RECENT DEVELOPMENTS 195
  • 12.3 OLYMPUS CORPORATION 196
    • 12.3.1 COMPANY OVERVIEW 196
    • 12.3.2 REVENUE ANALYSIS 196
    • 12.3.3 COMPANY SHARE ANALYSIS 197
    • 12.3.4 PRODUCT PORTFOLIO 197
    • 12.3.5 RECENT DEVELOPMENTS 197
  • 12.4 CAPSOVISION, INC. 198
    • 12.4.1 COMPANY OVERVIEW 198
    • 12.4.2 PRODUCT PORTFOLIO 198
    • 12.4.3 RECENT DEVELOPMENTS 199
  • 12.5 CHECK CAP 200
    • 12.5.1 COMPANY OVERVIEW 200
    • 12.5.2 GEOGRAPHIC PRESENCE 200
    • 12.5.3 PRODUCT PORTFOLIO 201
    • 12.5.4 RECENT DEVELOPMENTS 201
  • 12.6 INTROMEDIC 202
    • 12.6.1 COMPANY OVERVIEW 202
    • 12.6.2 PRODUCT PORTFOLIO 202
    • 12.6.3 RECENT DEVELOPMENTS 202
  • 12.7 JINSHAN SCIENCE & TECHNOLOGY 203
    • 12.7.1 COMPANY OVERVIEW 203
    • 12.7.2 PRODUCT PORTFOLIO 203
    • 12.7.3 RECENT DEVELOPMENTS 203
  • 12.8 LUCID GROUP LIMITED 204
    • 12.8.1 COMPANY OVERVIEW 204
    • 12.8.2 PRODUCT PORTFOLIO 204
    • 12.8.3 RECENT DEVELOPMENTS 204

13 RELATED REPORTS 205

Back to Top